MARA Holdings
MARA
MicroStrategy
MSTR
Tesla
TSLA
Coinbase
COIN
Amazon
AMZN
US Stock MarketDetailed Quotes
ANTX AN2 Therapeutics
- 1.420
- +0.030+2.16%
Close Jan 3 16:00 ET
- 1.400
- -0.020-1.41%
Post 20:01 ET
42.43MMarket Cap-0.71P/E (TTM)
1.440High1.340Low192.73KVolume1.340Open1.390Pre Close266.12KTurnover1.29%Turnover RatioLossP/E (Static)29.88MShares22.22052wk High0.48P/B21.22MFloat Cap0.87052wk Low--Dividend TTM14.94MShs Float23.580Historical High--Div YieldTTM7.19%Amplitude0.870Historical Low1.380Avg Price1Lot Size
About AN2 Therapeutics Company
AN2 Therapeutics, Inc. operates as a global health biopharmaceutical company. The firm focuses on modern biomedical and drug development to provide transformational medicines for patients suffering from infectious diseases. The company was founded by Eric Easom, George Harrison Talbot, Joseph S. Zakrzewski and Michael R.K. Alley and is headquartered in Menlo Park, CA.
Company Profile
SymbolANTX
Company NameAN2 Therapeutics
Listing DateMar 25, 2022
Issue Price15.00
Founded2017
CEOMr. Eric Easom
MarketNASDAQ
Employees41
Fiscal Year Ends12-31
Address1800 El Camino Real,Suite D
CityMenlo Park
ProvinceCalifornia
CountryUnited States of America
Zip Code94027
Phone1-650-331-9090
Company Executives
- Name
- Position
- Salary
- Eric Easom
- Chief Executive Officer, President and Director
- 3.34M
- Kevin Krause
- Chief Strategy Officer
- --
- Dr. Sanjay Chanda, PhD
- Chief Development Officer
- --
- Joshua M. Eizen, J.D.
- Chief Legal Officer and Chief Operating Officer
- --
- Lucy O. Day
- Chief Financial Officer and Principal Accounting Officer
- 1.52M
- Joseph S. Zakrzewski
- Chairman of the Board
- 179.64K
- Patricia Martin
- Independent Director
- 153.14K
- Dr. Melvin K. Spigelman,M.D.
- Independent Director
- 145.64K
- Kabeer Aziz
- Independent Director
- 145.64K
- Dr. Rob Readnour, PhD
- Independent Director
- 146.14K
- Stephanie Wong
- Independent Director
- 157.14K
- Margaret M. FitzPatrick, M.A.
- Independent Director
- 142.14K
- Gilbert Lynn Marks
- Independent Director
- 145.64K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.